etoposide has been researched along with n-(4-(5-bromo-2-pyrimidinyloxy)-3-chlorophenyl)-n'-(2-nitrobenzoyl)urea in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, F; Fujita, M; Inaba, H; Okuyama, Y; Sugimoto, T; Taguchi, T | 1 |
1 other study(ies) available for etoposide and n-(4-(5-bromo-2-pyrimidinyloxy)-3-chlorophenyl)-n'-(2-nitrobenzoyl)urea
| Article | Year |
|---|---|
[Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Division; Cisplatin; Doxorubicin; Drug Synergism; Etoposide; Humans; Mice; Mice, Nude; Mitomycin; Neoplasm Transplantation; Nitrobenzenes; Pancreatic Neoplasms; Stomach Neoplasms | 1991 |